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Abstract
Anaerobes used to be the most common cause of community-acquired lung abscess, and Streptococcus species used to be the 
second most common cause. In recent years, this has been changing. Klebsiella pneumoniae is now an increasing cause of commu-
nity-acquired lung abscess, but Streptococcus species continue to be major pathogens. Necrotizing pneumonia has generally been 
regarded as a rare complication of pneumococcal infection in adults. Type 3 Streptococcus pneumoniae was the single most com-
mon type implicated in necrosis; however, many other serotypes were implicated. This entity predominately infects children, but is 
present also in adults. Lung abscess in adults due to Streptococcus pneumoniae is not common. In this regard we present a case 
series of pulmonary cavitation due to Streptococcus pneumoniae and discuss the possible pathogenic mechanism of the disease. 
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Streszczenie
Bakterie beztlenowe stanowiły w przeszłości najczęstszy czynnik etiologiczny pozaszpitalnego ropnia płuca, Streptococcus był na 
kolejnej pozycji pod względem częstości. W ostatnich latach obraz ten uległ zmianie. Wzrosła liczba przypadków pozaszpitalnego 
ropnia płuca spowodowanego przez Klebsiella pneumoniae, nadal kolejnym co do częstości jest Streptococcus species. Martwicze 
zapalenie płuc jest rzadkim powikłaniem infekcji pneumokokowej u dorosłych. W tych przypadkach najczęsciej izolowano serotyp 
3 S. pneumoniae, jednak inne serotypy mogą również być przyczyną martwicy. Zakażenie serotypem 3 występuje głównie u dzieci, 
może być jednak zdiagnozowane również u dorosłych.
Ropień płuca u dorosłych wywołany przez szczep S. pneumoniae nie jest powikłaniem częstym. Z tego powodu w obecnej pracy 
przedstawiono serię przypadków, w których stwierdzono naciek płuca z rozpadem i wyhodowano S. pneumoniae. Omówiono także 
możliwe patomechanizmy choroby.
Słowa kluczowe: ropień płuca, Streptococcus pneumoniae, patomechanizm choroby
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Introduction
Anaerobes used to be the most common 
cause of community-acquired lung abscess, and 
Streptococcus species used to be the second most 
common cause of this problem. In recent years, 
this has changed. Klebsiella pneumoniae is now 
an increasing cause of community-acquired lung 
abscess [1], but Streptococcus species remain ma-
jor pathogens. In a recent retrospective review of 
205 patients, Takanayagi et al. [1] documented 122 
bacteriological results, with 189 bacterial species 
isolated. Pure aerobic, mixed aerobic and anaero-
bic, and pure anaerobic bacteria were isolated in 
90 (73.8%), 17 (13.9%) and 15 (12.3%) patients, 
respectively. The four most common aetiological 
pathogens were Streptococcus species 141 (59.8%), 
anaerobes (26.2%), Gemella species (9.8%) and 
Klebsiella pneumoniae (8.2%). Streptococcus mitis 
was the most common among the Streptococcus 
species. Streptococcus pneumoniae was found in 
three patients (2.12%) [1]. Necrotizing pneumonia 
has generally been regarded as a rare complica-
tion of pneumococcal infection in adults [2, 3]. 
Serotype 3 of Streptococcus pneumoniae was the 
single most common type implicated in necrosis; 
however, many other serotypes were implicated 
[2]. This entity predominately infects children, 
but is present also in adults (Table 1) [2]. In the 
USA and in Taiwan, infection with Streptococ-
cus pneumoniae serotype 3 (mainly ST180) was 
a significant contributor to necrotizing pneumonia 
and lung abscess [3]. In Taiwan, serotype 14 was 
another common serotype that caused necrotizing 
pneumonia. However, there is no monopoly among 
the serotypes; other serotypes, including 6B, 19F, 
23F and 19A, at a lower frequency, may also cause 
necrotizing pneumonia [4]. In a retrospective re-
view conducted by Yen et al. covering twenty years 
(1982–2002), 23 patients presented with a lung 
abscess; the most common micro-organism isolat-
ed was again Streptococcus pneumoniae [5]. Lung 
abscess in adults due to Streptococcus pneumoniae 
is not common, but it is not rare. In this regard we 
present a case series of pulmonary cavitation due 
to Streptococcus pneumoniae observed in our de-
partments in the last two years. 
Case series
Case 1
A 45-year-old man with a medical history 
that included only intermittent bronchial asth-
ma was admitted to the hospital with a 2-month 
history of productive cough, purulent sputum, 
low-grade fever, intermittent chest pain, asthenia 
and anorexia with accompanying weight loss 
(5 kg). He also complained of haemoptysis with 
an onset two days before presentation. On exam-
ination, the patient appeared ill, but not toxic: his 
temperature was 37°2, heart rate 78 bpm, respira-
tory rate 18 breaths/min, arterial blood pressure 
105/70 mm Hg and SaO2 was 99% on room air. 
Bronchial breath sounds were noted over the 
area of the right upper lung along with scattered 
crackles. Laboratory evaluation demonstrated 
a WBC count of 8540 cells/µl, with 74.5% neutrophils 
and 13.0% lymphocytes; RBC was 4,770,000 cells/ 
/µl; haemoglobin 14.0 g/dL; PLT count 283,000 cells/µl; 
C-reactive protein 3.51 mg/dL; LDH 255 U/l and 
total protein was 7.44 g/dL with 17.0% g-globulins. 
A chest radiograph showed consolidation with 
a cavitation inside at the right upper lobe (Fig. 1A). 
Chest computed tomography (CT) showed a spher-
ical cavitary pulmonary mass of 6.7 × 4.6 cm with 
air-fluid level at the level of the dorsal segment of 
the right upper lobe (Fig. 1B). Flexible bronchos-
copy revealed bronchial oedema with narrowing 
of the right lobar superior bronchus. Moreover, 
a small amount of purulent secretion was seen. 
A cytological examination showed inflammatory 
cells but no malignancy. Direct bacterioscopy and 
bacteriological analysis (cultures and polymerase 
chain reaction — PCR) performed on bronchoal-
veolar lavage and bronchoaspirate were negative 
for Mycobacterium tuberculosis. Because of the 
suspicion of an underlying malignancy, a CT-guided 
biopsy was performed in the right upper lobe. 
The cytological examination showed inflamma-
tory cells compatible with active inflammation, but 
no malignant cells were seen. A Gram-stained smear 
of sputum revealed numerous polymorphonuclear 
neutrophils and gram-positive cocci in pairs and 
chains; the culture eventually yielded Streptococcus 
pneumoniae. All the blood cultures collected upon 
admission were negative, as was the Streptococcus 
pneumoniae urinary antigen. A dental radiograph 
and a CT of nasal and paranasal sinuses did not 
show infectious foci. The minimum inhibitory con-
centrations breakpoint of penicillin G, ceftriaxone, 
erythromycin and imipenem were ≤ 0.06, ≤ 0.06, 
≥ 0.5 and ≤ 0.03, respectively. The biochemical and 
susceptibility profile of these strains was assayed 
using an automated system for identification and 
susceptibility tests (ViteK Bio Merieux SA, France). 
Criteria to define susceptibility or non-susceptibility 
were based on the Eucast guidelines (www.eucast.
org/clinical_breakpoints). The patient was treated 
with Amoxicillin/Clavulanate 2000 mg/200 mg IV 
every 8 hours for three weeks.The patient contin-
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Table 1. Cases of necrotizing pneumococcal pneumonia and lung abscess 
Reference Subjects N° of cases Blood or pleural culture N° of cases type/ 
/Pneumococcal serotype
Outcome
Danner 1968 Adults 2 Not done 1/serotype 7 1 death
Proctor 1977 Adults 1 Positive not typed alive
O’Reilly1978 Adults 1 Positive not typed alive
Yangco 1980 Adults 4 Positive 1/serotype 3
3/not typed
alive
Leathermann 1984 Adults 1 Positive not typed alive
Isaacs 1986 Adults 2 Positive 1/serotype 8
1/serotype 23
alive
Hammond 1993 Adults 1 Positive 1 not typed alive
Kerem 1994 Children 4 Positive 4 not typed alive
Donnelly 1998 Children 8 Not specified 8 not typed alive
Hoffer 1999 Children 6 One Positive 6 not typed alive
McCarthy 1999 Children 3 Positive 3 not typed alive
Wong 2000 Children 3 One Positive 3 not typed alive
Hodina 2002 Children 3 Not done 3 not typed alive
Yu 2003 Adults 4 Positive 4 not typed not specified
Kosucu 2004 Children 7 Positive 7 not typed alive
Hsieh 2004 Children 13 Positive 13 not specified not specified
Hsieh 2006 Children 14 Positive 5/serotype 14
2/serotype 3
1/serotype 6A
1/serotype 18C
5 not typed
alive
Ramphul 2006 Children 13 Positive 4/serotype 1
3/serotype 3
2 serotype 14
2/serotype 9
2 non typed
alive
Bender 2008 Children 33 Positive 11/serotype 3
4/serotype 19
4 /serotype 19A 3/serotype 1
2/serotype 6b
1/serotype 4
1/serotype 6A
1/serotype 7
1/serotype 19F
2/not typable
3 not typed
1 death
Fretzayas 2008 Children 10 Positive  10 not typed alive
Sawicki 2008 Children 18 Positive  18 not typed alive
Kalaskar 2009 Children 4 Positive 4/serotype 19A alive
ued the amoxicillin/clavulanate (875 mg/125 mg 
tablets every 8 hours) after the discharge for 
two weeks. After six weeks a chest CT showed 
a complete resolution of the lung abscess. 
Case 2
A 27-year-old man with a medical history that 
included no previous diseases was admitted to 
the hospital with a 1-month history of productive 
cough, light fever, asthenia, anorexia and severe 
weight loss (30 kg). At admission, his temperature 
was normal (36.5°C); on examination the patient 
appeared ill but not toxic, his temperature was 
37°2, heart rate 98 bpm, respiratory rate 18 breaths/ 
/min, blood pressure 100/66 mm Hg, and SaO2 
was 97% on room air. Bronchial breath sounds 
were noted over the right upper lung along with 
scattered crackles. Laboratory evaluation demon-
strated a WBC count of 10,700 cells/µl, with 75.5% 
neutrophils, 14.1% lymphocytes; RBC 4,140,000 
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cells/µl, haemoglobin level of 12.4 g/dL; PLT count 
of 241,000 cells/µl, C-reactive protein 8.05 mg/ 
/dL, LDH 201 UL, total protein 7.31 g/dL with 
15.1% of g-globulins. A chest radiograph showed 
an inhomogeneous opacity with blurred edges and 
irregular extension involving the right upper lobe 
with small cavitations inside (Fig. 2A). Chest CT 
showed a large pulmonary consolidation (10.7 × 
7.9 cm) with areas of cavitation at the level of the 
dorsal segment of the right upper lobe (Fig. 2B). 
The patient underwent bronchial fibrobronchos-
copy: bronchial oedema with narrowing of the 
bronchial lobar superior and a small amount of 
purulent secretion was seen. A cytological exam-
ination showed inflammatory cells but no malig-
nancy. All tests performed as in the previous case 
were negative for Mycobacterium tuberculosis. 
A Gram-stained smear of bronchial aspirate 
revealed numerous polymorphonuclear neutro-
phils and gram-positive cocci in pairs and chains; 
the culture eventually yielded Streptococcus 
pneumoniae. The MIC were identical to those 
of the previously described case. All the blood 
cultures collected upon admission were negative, 
as was Streptococcus pneumoniae urinary anti-
gen. A dental radiograph and a CT of nasal and 
paranasal sinuses did not show infectious foci. 
The patient was treated with Amoxicillin/ 
/Clavulanate 2000 mg/200 mg every 8 hours for 
three weeks and after the discharge with Amox-
icillin/Clavulanate (875 mg/125 mg tablets every 
8 hours) for a further three weeks. After eight 
weeks a CT of the chest showed complete reso-
lution of the lung abscess.
Case 3
A 35-year-old homeless man, presented 
in February 2012 at the emergency unit, with 
a 2-day history of fever, chest pain and dyspnea. 
He had lived in Spain for 3 years. The patient was 
a smoker with a history of alcohol abuse. On ad-
mission his respiratory rate was 40 breaths/min, 
Figure 2. A — chest radiograph shows a right upper cavitation; B — chest computed tomography: cavitary pulmonary lesion (10.7 × 7.9 cm) at 
the level of the dorsal segment of the right upper pulmonary lobe
A B
Figure 1. A — chest radiograph shows a right upper fluid-filled cavitation; B — chest computed tomography: spherical mass with air-fluid level 
(6.7 × 4.6 cm) at the level of the dorsal segment of the right upper lobe
A B
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SaO2 92%, temperature 38.80C, blood pressure 
155/110 and heart rate 140 bpm. On examination 
he was cyanotic with lividity. Lung auscultation 
revealed left-sided crackles. The laboratory stud-
ies on admission to ICU revealed elevated C-re-
active protein 22.1 mg/dL, WBC 14000 cells/µl 
with neutrophils 84% and lymphocytes 6%, in-
dicating bacterial infection. Chest X-ray and CT 
showed diffuse bilateral pulmonary ground-glass 
opacities, multiple small patchy consolidations 
in both lungs and a large consolidation with two 
cavitations in the left lower pulmonary lobe (Figs 
3A, B). Blood cultures, urinary antigen (pneumo-
coccus and legionella pn.) and nasopharyngeal 
swab for respiratory viruses were taken and 
empirical therapy with levofloxacin 500 mg/12 h 
plus ceftriaxone 1 g/24 h were established. In 
addition, therapy with oseltamivir and trime-
toprim-sulfamethoxazole was added; trimeto-
prim-sulphamethoxazole was stopped when the 
results of HIV were negative. The patient was 
isolated for prevention for influenza virus; on 
the 2nd day the test for influenza virus was noted 
to be negative and the patient was removed from 
the isolation room. Because of worsening of the 
clinical and respiratory conditions, the patient 
required initial ventilator settings with FiO2 
100%, positive end-expiratory pressure (PEEP) 
16 cm H2O and tidal volume 460 mL. The initial 
antibiotic treatment was modified for levofloxacin 
plus meropenem. The diagnosis of the patient was 
septic shock, bilateral pneumonia with severe 
respiratory failure. The aetiology of this severe 
illness seemed to be Streptococcus pneumoniae. 
Blood culture collected in the emergency depart-
ment on admission and urinary antigen were 
positive for Streptococcus pneumoniae, the strain 
was multi-sensitive and the serotype identified 
was 9V, nasofaringeal swab for respiratory viruses 
and antigen test for L. pneumophila were nega-
tive. Culture of tracheo-bronchial aspirate (BAS) 
on day 2 was positive for pneumococcus. On the 
5th day, blood cultures were positive for S. pneu-
moniae plus Streptococcus viridans. Therefore, 
antibiotic therapy was adjusted to meropenem 
plus vancomycin plus levofloxacin. Chest CT scan 
on the 9th day revealed dense opacities associated 
with reticular opacities in the left lobe; moreover, 
small bilateral pleural effusion, a small left pneu-
mothorax and bilateral, patchy consolidations 
associated with ground-glass opacities (Fig. 3C) 
were noted. 
A B
C
D
Figure 3. A — chest computed tomography (coronal reconstruction) diffuse bilateral ground-glass opacities; multiple small diffuse patchy con-
solidations in the lungs. A large dense opacity at the lower left pulmonary lobe. Two cavitations (abscesses) with thick walls and irregular inner 
edges in the medium-basal zone of the left pulmonary lobe; B — chest computed tomography (axial reconstruction) pulmonary dense opacities 
associated with reticular opacities, small pleural effusion and small pneumothorax in the left pulmonary lobe. Diffuse patchy opacities associated 
with ground-glass opacities and small pleural effusion; C — chest computed tomography: small pneumothorax, reduction of pulmonary consolida-
tion. Ground-glass opacities associated with bullous-cystic areas in the left lower lobe. Ground-glass opacities associated with patchy opacities 
and small pneumothorax in the right lower lobe
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On the 14th day, another chest CT scan was 
performed, revealing enlargement of the bilateral 
pleural effusions and bilateral small pneumotho-
races, as well as a reduction of pulmonary con-
solidation and ground-glass opacities associated 
with bullous cystic areas in the left lower lobe 
(Fig. 3D). Owing the severity of the respiratory 
failure, on the 16th day tracheotomy was per-
formed and invasive mechanical ventilation con-
tinued. For persistence of abundant secretions, 
a tracheo-bronchial aspirate was performed on 
the 24th day with results positive for Pseudomonas 
aeruginosa resistant to ciprofloxacin and imipe-
nem. Chest radiography showed impressive atel-
ectasis. The antibiotic regimen was again altered 
to ceftazidime plus amikacin. On the 32nd day the 
patient achieved clinical stability and invasive 
ventilation was stopped. 
Chest X-ray showed bilateral interstitial opac-
ities and a dense opacity in the middle-lower field 
of the left lung. New culture of BAS was negative. 
On the 36th day the patients was transferred to the 
ward and was discharged on the 42nd day.
Case 4
We describe a 49-year-old woman, who 
presented in January 2010 at the emergency de-
partment with a 4-day history of fever, vomiting 
and diarrhoea; the night before coming to the 
hospital she experienced syncope at home. The 
emergency services intubated the patient before 
arriving at hospital because of life-threatening 
hypoxia (SaO2 < 50% on FIO2 100%). She did 
not have toxic habits, and the family said that 
she had borderline personality disorder and 
suffered from recurrent otitis. On admission she 
had Glasgow Coma Scale 10 and nuchal rigidity 
was present. The laboratory studies on admission 
revealed elevated C-reactive protein 27.2 mg/dL, 
WBC 19000 cells/µl with neutrophils 76% and 
lymphocytes 3.3%.
Chest X-ray showed a subtotal consolidation 
of the right lung with sparing of the basal and api-
cal segments (Fig. 4A). Cerebrospinal fluid, blood 
cultures and tracheo-bronchial aspirate were ob-
tained. Empirical therapy with meropenem plus 
vancomycin was established. She was admitted 
to the ICU immediately. Cranial CT revealed 
possible inflammatory material in the ethmoid, 
maxillary and sphenoid sinuses. She presented 
haemodynamic instability and vasoactive support 
was necessary. The diagnosis of the patient was 
pneumococcal meningitis and pneumococcal 
pneumonia. The blood culture collected in the 
emergency department on admission was positive 
for coagulase-negative pathogens, the culture of 
cerebrospinal fluid and the BAS were positive for 
Streptococcus pneumoniae, the serotype was 12F. 
Therefore, levofloxacin 500 mg/12 h was added. 
On the 7th day, chest X-ray revealed large con-
A B
C D
Figure 4. A — chest X-ray. Large consolidation in medium-upper zone of the right lung; B — chest X-ray. Large consolidation and cavitation inside; 
C — chest computed tomography (coronal reconstruction) at day 18: cavitation with thick walls and irregular inner edges; D — chest X-ray at 
discharge: further reduction of the cavitation in the upper pulmonary lobe
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Table 2. Baseline characteristics, risk factors, symptoms, radiographic location, diagnostic methods and treatments of the 
four patients 
Patient 1 Patient 2 Patient 3 Patient 4
Sex Male Male Male Female
Age 45 y 27 y 35 y 49 y
Alcohol abuse – – ++ –
Smoking – – ++ –
Underlying disease Bronchial asthma – – Psychiatric disease
Fever + + ++ ++
Cough ++ + – –
Sputum ++ + – –
Haemoptysis + – – –
Chest pain – – ++ –
Anorexia + + – –
General malaise + + – +
Radiographic location  Right upper lobe Right upper lobe Left lower lobe Right lung
Pleural effusion – – + –
White blood cells 8540 10.700 14.000 19.700
Neutrophils% 74.5 75.5 84.0 76.0
Lymphocytes% 13.0 14.1 6.0 3.3
Reactive c-protein mg/dl 3.51 8.05 22.1 27.2
Blood culture – – + +
Tracheo-bronchial culture + + + +
Broncho-alveolar culture – – – –
Urinary antigen – – + –
Cerebro-spinal fluid – – – + 
Antibiotic therapy Amoxicillin/clavulanate Amoxicillin/clavulanate Meropenem + vancomycin 
+levofloxacin
Meropenem + vancomycin 
+ levofloxacin
solidation with a cavitary lesion inside (68 mm 
diameter) with thickened wall and irregular inner 
edges (compatible with lung abscess) (Fig. 4B). 
BAS was performed for secretions. CT-guided 
puncture of the cavitation was performed, which 
yielded pus. The culture of the sample obtained 
was negative. Genetic probe of Mycobacterium 
tuberculosis was negative. The patient was extu-
bated on the 16th day. Chest CT on the 18th day 
showed a large consolidation adhering to a large 
pleural fissure involving the right upper lobe and 
presenting a smaller size cavitation inside (Fig. 
4C). She was transferred to the ward on the 21st 
day and discharged seven days later with a further 
reduction of fluid-filled lung cavity presenting 
with thickened wall and irregular edges (Fig. 4D).
The clinical data of the four patients are sum-
marised in Table 2. Written, informed consent was 
obtained from the four patients for the publication 
of this case series and any accompanying images.
Discussion and conclusions
Diseases caused by Streptococcus pneumoni-
ae are a major public health problem worldwide. 
Invasive diseases caused by pneumococcus in-
clude pneumonia, meningitis, bacteraemia, and 
pneumonia with bacteraemia, lung abscess and/ 
/or empyema [6]. Currently 46 serogroups and 93 
serotypes have been documented; serotype 6C, 
serotype 6D, and serotype 11 are the latest addi-
tions [6]. The most severe pneumococcal disease 
most frequently affects individuals at extremes of 
age and those with immunological impairment 
(children or adults). 
Nevertheless, a significant proportion of 
adults who develop invasive infection have no 
apparent pre-existing risk factor [7–9]. Most cas-
es of severe pneumococcal disease are caused 
by a limited number of serotypes that vary in 
infectivity and virulence. Host and bacterial 
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factors both contribute to the pathogenicity. The 
coincidence of two key situations may lead to 
the development of disease (first, colonisation 
of the host with a pneumococcal serotype that 
it has not yet established immunity to, and sec-
ond, an alteration of the natural barriers or host 
immune system) [8]. Streptococcus pneumoniae 
frequently colonises the nasopharyngeal region; 
spread from the nasopharynx to the lower re-
spiratory tract or other sites may cause invasive 
disease. The nasopharyngeal carriage rate is 
highest in children, mainly during the first years 
of life (nasopharyngeal carriage rates range from 
20% to 50% of healthy children) rather than in 
the adult population (nasopharyngeal carriage 
rates range from 5% to 30% of healthy adults) 
[6]. Risk factors for nasopharyngeal carriage in 
children include winter season, age < 6 years, 
having young siblings and attendance in daycare 
centres. In adults, risk factors for nasopharyngeal 
carriage include cigarette smoking, asthma, and 
acute upper respiratory infection [6]. In children, 
colonisation may persist for a mean of 4 months, 
but this is much shorter in adults, usually 2 to 
4 weeks [10]. 
Transmission of pneumococcus from children 
to household contacts or adults is the principal 
cause of nasopharyngeal carriage and severe 
pneumococcal disease [6].
Not all pneumococcal serotypes are equally 
virulent; capsular polysaccharide is the major 
virulence factor, and those serotypes that produce 
large amounts of polysaccharide are likely to be 
more virulent than others. After invasion, the 
capsular polysaccharide also protects the patho-
gen by inhibiting neutrophil phagocytosis and 
classic complement-mediated bacterial killing. 
Some of the important factors in the development 
of pneumococcal disease include the invasive 
properties of the serotype, the ability of the organ-
ism to evade the immune system and the absence 
of a type-specific pneumococcal antibody [11]. 
Ethnicity (African Americans, American Indians, 
Native Alaskans and Australian Aborigines), 
extremes of age (< 2 or > 65 years), existence of 
comorbidities (pulmonary, neurological, hepatic, 
diabetes mellitus, renal conditions — especially 
renal insufficiency or nephrotic syndrome, al-
coholism and immunosuppression — asplenia, 
human immunodeficiency virus, and sickle cell 
anaemia — anatomic abnormalities — cerebro-
spinal fluid leak, cochlear implant or congen-
ital heart disease) are well-known risk factors 
associated with an increased susceptibility to 
severe pneumococcal infection and are further 
associated with higher mortality [6]. Asplenia and 
spleen disfunction are linked to specific defects 
in host responses due to low levels of antibodies 
and complement factors; the combination of these 
defects contributes to increased rates of more 
severe pneumococcal disease [7–9].
In contrast, exposure to cigarette smoke and 
multiple children in the household are risk factors 
in healthy children. In the case of immunocompe-
tent adults, the incidence of severe pneumococcal 
disease is increased with the following comor-
bidities: congestive heart failure, chronic lung 
disease, asthma, diabetes mellitus and neurolog-
ical disorders. Alcohol abuse, cigarette smoking, 
recent influenza infection, institutionalisation, 
male sex and black race are also risk factors in 
this population [6].
In the past, Staphylococcus aureus was fre-
quently the aetiological agent of lung abscess. In 
recent years, Streptococcus pneumoniae has been 
implicated more often [12, 13]. A lung abscess 
is an area of suppuration and necrosis involving 
one or more areas of the lung parenchyma [14]. 
Abscesses form as a consequence of infection 
and destruction of the lung parenchyma with 
central necrosis, leading to cavity formation. The 
characteristic radiograph finding is an air-fluid 
level on the chest radiograph [14, 15]. A lung 
abscess may decompress and eventually resolve, 
if it communicates with the tracheobronchial 
tree; however, if no communication develops 
surrounding the necrotic lung, purulent material 
becomes thick and fibrotic. Lung abscesses can 
result from widely variable pathogenic process-
es, including necrotizing pneumonia, aspiration 
pneumonia, focal infection of the lung during 
high-grade bacteraemia, or as a consequence of 
septic emboli or subacute airway infection. Con-
ditions contributing to this pathogenic process 
include cystic fibrosis, tracheoesophageal fistula, 
gastroesophageal reflux, immunodeficiency, alco-
hol or drug use, acute and chronic aspiration and 
poor dentition [14].
Pneumonia, high-grade bacteraemia or septic 
emboli also predispose patients to abscess forma-
tion. Necrotizing community-acquired pneumo-
nia is the most common underlying condition 
(particularly in children) with lung abscess [5, 
14, 16]. 
Lung abscess could be also classified in two 
groups: 1) primary lung abscesses, which occur 
without other underlying disease processes, 
and which are a direct result of pneumonia or 
aspiration; 2) secondary lung abscesses, which 
develop in those with an underlying medical 
Pneumonologia i Alergologia Polska 2014, tom 82, nr 3, strony 276–285 
284 www.pneumonologia.viamedica.pl
condition such as immunocompromised states, 
other lung diseases, central nervous system 
disorders and congenital heart diseases. The 
abscesses are located predominantly in poste-
rior segments of the upper lobes or in superior 
segments of the lower lobes. They are typically 
singular and appear with equal frequency on the 
right or left side. Multiple or bilateral abscesses 
are rarely caused by aspiration, when a present 
pathogenic mechanism other than aspiration 
(for example, an extrapulmonary focus) should 
be suspected [17]. The presence of pericavitary 
lesions and pulmonary consolidation foci located 
far from a cavitary lesion suggest tuberculosis. 
Both clinical examination and postero-anterior 
coupled with lateral chest X-ray most frequently 
clearly identify the characteristics and location 
of these lesions. It is possible to visualise the 
air-fluid levels within the cavities [17]. Chest CT 
and endoscopic procedures are important in the 
analysis of the condition of the drainage bronchus 
and the abscess cavity wall, especially for making 
differential diagnosis of lung carcinoma [17]. 
A high number of patients undergo bronchoscopy, 
despite current recommendations, which suggest 
that this invasive technique should only be used 
in atypical cases and/or in those with a high degree 
of suspicion of mechanical obstruction [18, 19]. 
The duration of antibiotic administration in 
previous reports was estimated to be from 28 to 
48 days and it was consistent with our results 
[1, 18, 20, 21].
A recent study in an adult population, 
concerning pulmonary complications of pneu-
mococcal pneumonia, showed that 38% of this 
cohort had pulmonary complications (e.g. nec-
rotizing pneumonia and empyema). Patients 
with pulmonary complications were younger, 
had less comorbidity and a longer length of 
hospital stay, more frequent admission to ICU, 
but a mortality rate similar to uncomplicated 
pneumonia [22]. Our four patients (although 
they presented different clinical pictures) were 
all young, and two of them had no comorbidity; 
all of them had a long hospital stay and none 
died. The first two patients had an onset of clin-
ical symptoms with low grade fever, asthenia, 
anorexia and weight loss and absence of typical 
pneumococcal infection symptoms. In these cas-
es diagnostic procedures must be considered for 
a differential diagnosis of lung cancer, pulmonary 
tuberculosis, pulmonary sarcoidosis, pulmonary 
haematoma and Wegener‘s pulmonary vasculi-
tis [23]. While the majority of pneumococcal 
pneumonia cases are non-bacteraemic (60–80%), 
bacteraemic pneumonia is generally more severe 
[22]. The patients in the last two cases showed 
the presence of bacteria in blood cultures, and 
one of them also in cerebrospinal fluid. They 
were admitted to intensive care. Also, the se-
rotypes found in our cases were extremely rare 
compared to most cases of pneumonia and/or 
pulmonary abscess [4, 24, 25]. The same is true 
in the patient with spinal meningitis [24, 25]. 
To our knowledge, this is the first time that 12F 
Streptococcus p. has been reported as the cause 
of pulmonary abscess. The incidence of pneumo-
coccal pneumonia is greatest at the extremes of 
age and in individuals with medical comorbid-
ity, but its complications usually involve young 
and healthy patients. Pneumococci colonise 
the nasopharynx and from there can spread 
directly via the airway to the lower respiratory 
tract, causing lower infectious disease. The on-
going evolution of pneumococci will continue 
to challenge researchers and clinicians; areas of 
future attention will be discovering early stages 
of the disease. Such knowledge could be useful 
to better stratify patients at risk [26].
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